VISTNVistin Pharma ASA
19.30NOK0.00%Mkt Cap: 80.00M $P/E: 12.223d ago
Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) in Africa, Europe, Asia, and North and South America. It offers metformin HCl; m…
Industry Peers
Drug Manufacturers - Specialty & Generic$65.19BUSDP/E 23.7
$58.06BUSD
$43.98BUSDP/E 20.4
$43.51BUSDP/E 62.2
$29.89BUSDP/E 12.7
$32.12BUSDP/E 12.7
$22.01BUSDP/E 18.4
$18.75BUSD
$15.34BUSDP/E 117.3
$14.67BUSDP/E 26.4
$15.51BUSDP/E 22.3
$11.98BUSD
$10.15BUSDP/E 29.7
$8.66BUSDP/E 19.0
$8.11BUSDP/E 127.2
$7.88BUSD
$6.53BUSDP/E 23.9
$6.24BUSDP/E 37.3
$6.14BUSDP/E 49.0
$6.08BUSDP/E 79.8
| Headline | Source | Time |
|---|---|---|
Older | ||
Vistin Pharma ASA (STU:VP4) (Q2 2026) Earnings Call Highlights: Strategic Resilience Amid ... Vistin Pharma ASA (STU:VP4) navigates a 9% revenue dip with strong 66% gross margins, while advancing its new DC 95% product and securing long-term energy stability. | ||